A Single-Center, Open-Label, Two-Period Crossover Study to Investigate the Effect of Multiple Doses of Activated Charcoal on the Pharmacokinetics of a Single Oral Dose of RO4995819 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 10 Jun 2016
At a glance
- Drugs Decoglurant (Primary) ; Charcoal
- Indications Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Roche
- 23 May 2013 Actual end date changed from Apr 2012 to Feb 2012 as reported by ClinicalTrials.gov.
- 28 May 2012 Actual end date (April 2012) added as reported by ClinicalTrials.gov.
- 18 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.